The Clareon PanOptix lens is an intraocular lens that is implanted during cataract surgery after the cataract has been removed. In contrast to a standard monofocal lens, the PanOptix lens has the ability to treat presbyopia, a condition that prevents patients from seeing both far and near at the same time.
This lens is recently FDA approved and is the first to be classified as a trifocal intraocular lens. It is the next evolution in the treatment of presbyopia, building from its predecessor, the ReSTOR multifocal lens.
[Read more…]



